Corvus Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Corvus Pharmaceuticals, Inc. (CRVS) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 400.00 thousand shares as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2024-11-12
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 400.00K shares.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 400.00K shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 400.00K shares.
- 2019-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 12.38K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2024-09-30 | 400.00K shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 400.00K shares 10-Q · filed 2024-08-06 |
| 2023-12-31 | 400.00K shares 10-Q · filed 2024-11-12 |
| 2019-06-30 | 12.38K shares 10-Q · filed 2019-08-01 |
| 2019-03-31 | 27.07K shares 10-Q · filed 2019-05-09 |
| 2018-12-31 | 43.08K shares 10-K · filed 2021-03-25 |
| 2018-09-30 | 99.83K shares 10-Q · filed 2018-11-01 |
| 2018-06-30 | 172.96K shares 10-Q · filed 2018-08-02 |
| 2018-03-31 | 246.08K shares 10-Q · filed 2018-05-03 |
| 2017-12-31 | 319.20K shares 10-K · filed 2020-03-09 |
| 2017-09-30 | 392.33K shares 10-Q · filed 2017-11-02 |
| 2017-06-30 | 465.45K shares 10-Q · filed 2017-08-03 |
| 2017-03-31 | 538.58K shares 10-Q · filed 2017-05-04 |
| 2016-12-31 | 611.70K shares 10-K · filed 2019-03-07 |
| 2016-09-30 | 684.83K shares 10-Q · filed 2016-11-03 |
| 2016-06-30 | 770.55K shares 10-Q · filed 2016-08-04 |
| 2016-03-31 | 840.24K shares 10-Q · filed 2016-05-05 |
| 2015-12-31 | 924.53K shares 10-K · filed 2018-03-01 |
| 2014-12-31 | 768.71K shares 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |